College News

Ana J. Chucair-Elliott, Ph.D., an assistant professor of ophthalmology at the University of Oklahoma College of Medicine and research member of Dean McGee Eye Institute, has been funded by the BrightFocus Foundation to investigate how aging, diet and inflammation contribute to retinal pigment epithelium (RPE) degeneration, a deterioration of the layer of cells in the back of the eye.

After a decade of service to OU, Dr. James M. Herman recently shared his intent to retire at the end of June.

University of Oklahoma researchers have discovered that some bacteria in the gut have their own unique “weapon system” to compete against other bacteria for dominance. Importantly, there is promising evidence that this system can be repurposed to target diseased cells like cancer.

Two researchers from the University of Oklahoma are partnering with Oklahoma start-up Xironetic to develop innovative methods for neurosurgical guidance, visualization and training.

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to improve liver function.